K200597 is an FDA 510(k) clearance for the Straumann BLX Gold Abutments. Classified as Abutment, Implant, Dental, Endosseous within the NHA classification (a category for dental implant abutments and prosthetic components), Class II - Special Controls.
Submitted by Straumann USA, LLC (On Behalf of Institut Straumann Ag) (Andover, US). The FDA issued a Cleared decision on August 19, 2020 after a review of 163 days - an extended review cycle.
This device falls under the Dental FDA review panel, regulated under 21 CFR 872.3630 - the FDA dental device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Dental review framework, consistent with the majority of Class II 510(k) submissions.
View all Straumann USA, LLC (On Behalf of Institut Straumann Ag) devices